QULIPTA
QULIPTA
Approved
DIN Number
02533995
Drug Class
Human
Market Date
Mar 1, 2023
Company
HC
Abbvie Corporation
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02533995
AIG Number0164361003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N02CD07 ATOGEPANT
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:32.12
Health Canada Classification
ACTIVE INGREDIENTS (1)
ATOGEPANTActive
Strength: 60 MG
Monograph: ATOGEPANT